Gate2Brain
  • Home
  • Company
    • Mission & vision
    • Awards & Recognitions
    • Seals & Product Designations
    • Supported by
  • About us
    • Founders
    • Team
    • Advisory board
    • Values
  • Technology
    • Scientific Publications
  • Pipeline-Proof of Concept
  • Investors
  • News & Media
  • Contact
  • Menu Menu

Navigating the ecosystem of pharma companies and investors at JP Morgan-RESI

Events, Funding & Breakthroughs, News

Navigating the vibrant ecosystem of pharma companies and investors during J.P. Morgan San Francisco and its dynamic side events is an incredible journey for Gate2Brain!

We are actively strengthening our network, expanding it, and breaking barriers—literally and figuratively. The enthusiasm and validation we are receiving for delivery systems that cross the blood-brain barrier is truly inspiring.

Gate2Brain’s platform is positioned to address this growing interest, especially with our upcoming publication showcasing the use of our shuttles to transport mAbs and ADCs.

To top it all off, we had the privilege of pitching at RESIJPM , sharing our vision and progress with some of the most forward-thinking minds in the industry.

Stay tuned for more exciting developments from Gate2Brain as we continue pushing boundaries in brain-targeted delivery system!

January 16, 2025/by noticias
Tags: JP Morgan, RESI
Share this entry
  • Share on Facebook
  • Share on Twitter
  • Share on WhatsApp
  • Share on LinkedIn
  • Share by Mail
https://gate2brain.com/wp-content/uploads/2025/01/JP-morgan.png 380 520 noticias https://gate2brain.com/wp-content/uploads/2020/12/Logo-Gate1Brain500pxGrueso.png noticias2025-01-16 17:10:312025-02-19 08:54:49Navigating the ecosystem of pharma companies and investors at JP Morgan-RESI
You might also like
Gate2Brain will be attending RESI JMP San Francisco 2025
Winner of the Innovator’s Pitch Challenge Award at RESI Europe 2024
Breaking Barriers in Science: The Journey of Meritxell Teixidó and Gate2Brain

CATEGORIES

  • Advisory Board
  • Events
  • Funding & Breakthroughs
  • Interviews
  • Media & Press
  • Media Coverage
  • News
  • Podcasts
  • Press releases
  • Research & Publications
  • Sin categoría
  • Video Content

Events

  • Bioengineering the Future of Drug Delivery workshop – PortoApril 8, 2025 - 10:03
  • Gate2Brain at the 2nd Peptide-Based Therapeutics Summit | BostonMarch 26, 2025 - 15:34
  • 4YFN 2025March 6, 2025 - 19:45
  • Keystone Symposia on Drug Delivery to the Brain: Emerging ModalitiesFebruary 21, 2025 - 11:10
  • Gate2Brain at ACCELERATE 2025: A Decade of Impact and Future Innovations in Pediatric OncologyFebruary 20, 2025 - 10:19

SOCIAL

  • linkedin
  • youtube
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

  • linkedin
  • youtube
© Copyright –Edisenius
  • Privacy Policy
  • Legal Notice
  • Cookie Policy
Companies to Watch 2025Meet the Advisory Board – Andrés G. Fernández
Scroll to top
Manage Cookie Consent
This Website uses proprietary and third-party cookies to improve services and facilitate browsing. You can obtain further information about the cookies this site uses and how to limit them in the
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}